The cholesterol lowering biologic drugs offers a new, revolutionary alternative for people fighting with cholesterol with the same old treatments. The old method of treating cholesterol elevated levels includes a change in diet and consuming statin pills to prevent the body from making more bad cholesterol. The new class of PCSK-9 inhibitors is being approved by the FDA which works by helping the liver flush out the bad cholesterol instead of preventing the body from making low-density lipoproteins. The FDA has till now approved only two drugs Praluent and Repatha, both made from living things. The PCSK-9 is a protein which binds to the receptors, those which are responsible for getting the bad cholesterol out of the body.
The cholesterol lowering biologics drug market is expected to boom owing to the number of population with high cholesterol levels, sedentary lifestyle and increasing research developments. According to the Indian Council of Medical Research, at least three-fourth of the country
The cholesterol lowering biologics drug market is expected to boom owing to the number of population with high cholesterol levels, sedentary lifestyle and increasing research developments. According to the Indian Council of Medical Research, at least three-fourth of the country
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Cholesterol Lowering Biologic Drugs Market Size Growth Rate by Type (2019-2025)
1.3.2 For Oral Administration
1.3.3 Injectable Drugs
1.4 Market Segment by Application
1.4.1 Global Cholesterol Lowering Biologic Drugs Market Share by Application (2019-2025)
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Drug Stores
1.4.5 Online Sales
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cholesterol Lowering Biologic Drugs Market Size
2.1.1 Global Cholesterol Lowering Biologic Drugs Revenue 2014-2025
2.1.2 Global Cholesterol Lowering Biologic Drugs Sales 2014-2025
2.2 Cholesterol Lowering Biologic Drugs Growth Rate by Regions
2.2.1 Global Cholesterol Lowering Biologic Drugs Sales by Regions 2014-2019
2.2.2 Global Cholesterol Lowering Biologic Drugs Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Cholesterol Lowering Biologic Drugs Sales by Manufacturers
3.1.1 Cholesterol Lowering Biologic Drugs Sales by Manufacturers 2014-2019
3.1.2 Cholesterol Lowering Biologic Drugs Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Cholesterol Lowering Biologic Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Cholesterol Lowering Biologic Drugs Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Cholesterol Lowering Biologic Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Cholesterol Lowering Biologic Drugs Price by Manufacturers
3.4 Key Manufacturers Cholesterol Lowering Biologic Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Cholesterol Lowering Biologic Drugs Market
3.6 Key Manufacturers Cholesterol Lowering Biologic Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 For Oral Administration Sales and Revenue (2014-2019)
4.1.2 Injectable Drugs Sales and Revenue (2014-2019)
4.2 Global Cholesterol Lowering Biologic Drugs Sales Market Share by Type
4.3 Global Cholesterol Lowering Biologic Drugs Revenue Market Share by Type
4.4 Cholesterol Lowering Biologic Drugs Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Cholesterol Lowering Biologic Drugs Sales by Application
6 United States
6.1 United States Cholesterol Lowering Biologic Drugs Breakdown Data by Company
6.2 United States Cholesterol Lowering Biologic Drugs Breakdown Data by Type
6.3 United States Cholesterol Lowering Biologic Drugs Breakdown Data by Application
7 European Union
7.1 European Union Cholesterol Lowering Biologic Drugs Breakdown Data by Company
7.2 European Union Cholesterol Lowering Biologic Drugs Breakdown Data by Type
7.3 European Union Cholesterol Lowering Biologic Drugs Breakdown Data by Application
8 China
8.1 China Cholesterol Lowering Biologic Drugs Breakdown Data by Company
8.2 China Cholesterol Lowering Biologic Drugs Breakdown Data by Type
8.3 China Cholesterol Lowering Biologic Drugs Breakdown Data by Application
9 Rest of World
9.1 Rest of World Cholesterol Lowering Biologic Drugs Breakdown Data by Company
9.2 Rest of World Cholesterol Lowering Biologic Drugs Breakdown Data by Type
9.3 Rest of World Cholesterol Lowering Biologic Drugs Breakdown Data by Application
9.4 Rest of World Cholesterol Lowering Biologic Drugs Breakdown Data by Countries
9.4.1 Rest of World Cholesterol Lowering Biologic Drugs Sales by Countries
9.4.2 Rest of World Cholesterol Lowering Biologic Drugs Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Amgen
10.1.1 Amgen Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Cholesterol Lowering Biologic Drugs
10.1.4 Cholesterol Lowering Biologic Drugs Product Introduction
10.1.5 Amgen Recent Development
10.2 Regeneron Pharmaceuticals
10.2.1 Regeneron Pharmaceuticals Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Cholesterol Lowering Biologic Drugs
10.2.4 Cholesterol Lowering Biologic Drugs Product Introduction
10.2.5 Regeneron Pharmaceuticals Recent Development
10.3 Alnylam Pharmaceuticals
10.3.1 Alnylam Pharmaceuticals Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Cholesterol Lowering Biologic Drugs
10.3.4 Cholesterol Lowering Biologic Drugs Product Introduction
10.3.5 Alnylam Pharmaceuticals Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Cholesterol Lowering Biologic Drugs Sales Channels
11.2.2 Cholesterol Lowering Biologic Drugs Distributors
11.3 Cholesterol Lowering Biologic Drugs Customers
12 Market Forecast
12.1 Global Cholesterol Lowering Biologic Drugs Sales and Revenue Forecast 2019-2025
12.2 Global Cholesterol Lowering Biologic Drugs Sales Forecast by Type
12.3 Global Cholesterol Lowering Biologic Drugs Sales Forecast by Application
12.4 Cholesterol Lowering Biologic Drugs Forecast by Regions
12.4.1 Global Cholesterol Lowering Biologic Drugs Sales Forecast by Regions 2019-2025
12.4.2 Global Cholesterol Lowering Biologic Drugs Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
1 Report Overview
1.1 Study Scope
1.2 Major Manufacturers Covered in This Report
1.3 Market Segment by Type
1.3.1 Global Cholesterol Lowering Biologic Drugs Market Size Growth Rate by Type (2019-2025)
1.3.2 For Oral Administration
1.3.3 Injectable Drugs
1.4 Market Segment by Application
1.4.1 Global Cholesterol Lowering Biologic Drugs Market Share by Application (2019-2025)
1.4.2 Hospital Pharmacies
1.4.3 Retail Pharmacies
1.4.4 Drug Stores
1.4.5 Online Sales
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cholesterol Lowering Biologic Drugs Market Size
2.1.1 Global Cholesterol Lowering Biologic Drugs Revenue 2014-2025
2.1.2 Global Cholesterol Lowering Biologic Drugs Sales 2014-2025
2.2 Cholesterol Lowering Biologic Drugs Growth Rate by Regions
2.2.1 Global Cholesterol Lowering Biologic Drugs Sales by Regions 2014-2019
2.2.2 Global Cholesterol Lowering Biologic Drugs Revenue by Regions 2014-2019
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
3 Market Share by Manufacturers
3.1 Cholesterol Lowering Biologic Drugs Sales by Manufacturers
3.1.1 Cholesterol Lowering Biologic Drugs Sales by Manufacturers 2014-2019
3.1.2 Cholesterol Lowering Biologic Drugs Sales Market Share by Manufacturers 2014-2019
3.2 Revenue by Manufacturers
3.2.1 Cholesterol Lowering Biologic Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Cholesterol Lowering Biologic Drugs Revenue Share by Manufacturers (2014-2019)
3.2.3 Global Cholesterol Lowering Biologic Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Cholesterol Lowering Biologic Drugs Price by Manufacturers
3.4 Key Manufacturers Cholesterol Lowering Biologic Drugs Plants/Factories Distribution and Area Served
3.5 Date of Key Manufacturers Enter into Cholesterol Lowering Biologic Drugs Market
3.6 Key Manufacturers Cholesterol Lowering Biologic Drugs Product Offered
3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Sales and Revenue for Each Type
4.1.1 For Oral Administration Sales and Revenue (2014-2019)
4.1.2 Injectable Drugs Sales and Revenue (2014-2019)
4.2 Global Cholesterol Lowering Biologic Drugs Sales Market Share by Type
4.3 Global Cholesterol Lowering Biologic Drugs Revenue Market Share by Type
4.4 Cholesterol Lowering Biologic Drugs Price by Type
5 Market Size by Application
5.1 Overview
5.2 Global Cholesterol Lowering Biologic Drugs Sales by Application
6 United States
6.1 United States Cholesterol Lowering Biologic Drugs Breakdown Data by Company
6.2 United States Cholesterol Lowering Biologic Drugs Breakdown Data by Type
6.3 United States Cholesterol Lowering Biologic Drugs Breakdown Data by Application
7 European Union
7.1 European Union Cholesterol Lowering Biologic Drugs Breakdown Data by Company
7.2 European Union Cholesterol Lowering Biologic Drugs Breakdown Data by Type
7.3 European Union Cholesterol Lowering Biologic Drugs Breakdown Data by Application
8 China
8.1 China Cholesterol Lowering Biologic Drugs Breakdown Data by Company
8.2 China Cholesterol Lowering Biologic Drugs Breakdown Data by Type
8.3 China Cholesterol Lowering Biologic Drugs Breakdown Data by Application
9 Rest of World
9.1 Rest of World Cholesterol Lowering Biologic Drugs Breakdown Data by Company
9.2 Rest of World Cholesterol Lowering Biologic Drugs Breakdown Data by Type
9.3 Rest of World Cholesterol Lowering Biologic Drugs Breakdown Data by Application
9.4 Rest of World Cholesterol Lowering Biologic Drugs Breakdown Data by Countries
9.4.1 Rest of World Cholesterol Lowering Biologic Drugs Sales by Countries
9.4.2 Rest of World Cholesterol Lowering Biologic Drugs Revenue by Countries
9.4.3 Japan
9.4.4 Korea
9.4.5 India
9.4.6 Southeast Asia
10 Company Profiles
10.1 Amgen
10.1.1 Amgen Company Details
10.1.2 Company Description and Business Overview
10.1.3 Sales, Revenue and Market Share of Cholesterol Lowering Biologic Drugs
10.1.4 Cholesterol Lowering Biologic Drugs Product Introduction
10.1.5 Amgen Recent Development
10.2 Regeneron Pharmaceuticals
10.2.1 Regeneron Pharmaceuticals Company Details
10.2.2 Company Description and Business Overview
10.2.3 Sales, Revenue and Market Share of Cholesterol Lowering Biologic Drugs
10.2.4 Cholesterol Lowering Biologic Drugs Product Introduction
10.2.5 Regeneron Pharmaceuticals Recent Development
10.3 Alnylam Pharmaceuticals
10.3.1 Alnylam Pharmaceuticals Company Details
10.3.2 Company Description and Business Overview
10.3.3 Sales, Revenue and Market Share of Cholesterol Lowering Biologic Drugs
10.3.4 Cholesterol Lowering Biologic Drugs Product Introduction
10.3.5 Alnylam Pharmaceuticals Recent Development
11 Value Chain and Sales Channels Analysis
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 Cholesterol Lowering Biologic Drugs Sales Channels
11.2.2 Cholesterol Lowering Biologic Drugs Distributors
11.3 Cholesterol Lowering Biologic Drugs Customers
12 Market Forecast
12.1 Global Cholesterol Lowering Biologic Drugs Sales and Revenue Forecast 2019-2025
12.2 Global Cholesterol Lowering Biologic Drugs Sales Forecast by Type
12.3 Global Cholesterol Lowering Biologic Drugs Sales Forecast by Application
12.4 Cholesterol Lowering Biologic Drugs Forecast by Regions
12.4.1 Global Cholesterol Lowering Biologic Drugs Sales Forecast by Regions 2019-2025
12.4.2 Global Cholesterol Lowering Biologic Drugs Revenue Forecast by Regions 2019-2025
12.5 United States Market Forecast
12.6 European Union Market Forecast
12.7 China Market Forecast
12.8 Rest of World
12.8.1 Japan
12.8.2 Korea
12.8.3 India
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
